Gene Therapy

RESEARCH TRIANGLE PARK – Asklepios BioPharmaceutical (AskBio), a clinical stage gene therapy company in Research Triangle Park, has acquired BrainVectis,…

CHAPEL HILL – Most research about the genetics of schizophrenia has sought to understand the role that genes play in…

RALEIGH – Research at North Carolina State University shows that the CRISPR-Cas system can be used to effectively target and…

CHAPEL HILL – Scientists at the UNC School of Medicine and colleagues created a new computational tool called H-MAGMA to…

CHAPEL HILL – A hallmark of triple negative breast cancer, an aggressive breast cancer type, is the accumulation of errors…

NEW YORK, N.Y. —  Biopharmaceutical company Hoth Therapeutics has tapped NC State to collaborate and carry out a preclinical study…

RESEARCH TRIANGLE PARK — For the better part of four decades, North Carolina has steadily committed resources to developing biotechnologies…

DURHAM — bluebird bio, a gene therapy company with operations in Durham, has launched for the first time its treatment…

Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, will conduct the world’s first clinical trial of a recombinant bacteriophage…